{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:36:15Z","timestamp":1790483775763,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","trasci.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.transci.2016.12.014","type":"journal-article","created":{"date-parts":[[2016,12,30]],"date-time":"2016-12-30T08:30:51Z","timestamp":1483086651000},"page":"31-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Use of convalescent plasma in Ebola virus infection"],"prefix":"10.1016","volume":"56","author":[{"given":"Olivier","family":"Garraud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2016.12.014_bib0005","unstructured":"World Health Organization http:\/\/www.who.int\/mediacentre\/factsheets\/fs103\/en\/; Accessed June 24, 2016."},{"key":"10.1016\/j.transci.2016.12.014_bib0010","unstructured":"World Health Organization http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/end-of-ebola-pheic\/en\/; Accessed June 24, 2016"},{"key":"10.1016\/j.transci.2016.12.014_bib0015","unstructured":"World Health Organization http:\/\/www.msf.fr\/actualite\/dossiers\/urgence-ebolahttp:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/end-of-ebola-pheic\/en\/http:\/\/www.who.int\/mediacentre\/news\/statements\/2016\/end-of-ebola-pheic\/en\/; Accessed June 24, 2016."},{"key":"10.1016\/j.transci.2016.12.014_bib0020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMsr1513109","article-title":"Ebola response team after ebola in west Africa\u2013unpredictable risks, preventable epidemics","volume":"375","author":"WHO","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/HAB-150284","article-title":"The emergence of antibody therapies for Ebola","volume":"23","author":"Hiatt","year":"2015","journal-title":"Hum Antibodies"},{"key":"10.1016\/j.transci.2016.12.014_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.transci.2014.11.007","article-title":"World Apheresis Association Board. World Apheresis Association letter to the WHO: the World Apheresis Association urges the development of preparedness plans to make specific plasma available when urgently needed","volume":"51","author":"Garraud","year":"2014","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2016.12.014_bib0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(14)61693-7","article-title":"Ebola: a call for blood transfusion strategy in sub-Saharan Africa","volume":"384","author":"Burnouf","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.transci.2016.12.014_bib0040","doi-asserted-by":"crossref","first-page":"964","DOI":"10.4161\/hv.27813","article-title":"Antibody therapy for Ebola: is the tide turning around?","volume":"10","author":"Qiu","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.transci.2016.12.014_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tracli.2015.12.003","article-title":"Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow","volume":"23","author":"Garraud","year":"2016","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.transci.2016.12.014_bib0050","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: conva- lescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Int Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0055","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections","volume":"38","author":"Luke","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0060","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunolobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/CCM.0b013e3182771386","article-title":"Clinical research during a public health emergency: a systematic review of severe pandemic influenza management","volume":"41","author":"Ortiz","year":"2013","journal-title":"Crit Care Med"},{"issue":"August 11","key":"10.1016\/j.transci.2016.12.014_bib0070","article-title":"Zika-induced antibody response enhances dengue serotype 2 replication in vitro","author":"Kawiecki","year":"2016","journal-title":"J Infect Dis"},{"issue":"August 15","key":"10.1016\/j.transci.2016.12.014_bib0075","article-title":"Plasmodium parasitemia associated with increased survival in ebola virus-infected patients","author":"Rosenke","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"June 6 Suppl. (1)","key":"10.1016\/j.transci.2016.12.014_bib0080","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1097\/TA.0000000000000631","article-title":"Syndecan-1 restitution by plasma after hemorrhagic shock","volume":"78","author":"Kozar","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.transci.2016.12.014_bib0085","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0035-9203(84)90107-X","article-title":"The use of Lassa fever con- valescent plasma in Nigeria","volume":"78","author":"Frame","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.transci.2016.12.014_bib0090","article-title":"Early and repeated use of plasma for the management of Ebola patients: \u00e0 propos one case","author":"Dufour-Gaume","year":"2016","journal-title":"Tranfus Clin Biol"},{"key":"10.1016\/j.transci.2016.12.014_bib0095","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1128\/JVI.75.10.4649-4654.2001","article-title":"Passive transfer of antibodies protect immunocompetent and immunodeficient mice against letal Ebola virus infection without complete inhibition of viral replication","volume":"75","author":"Gupta","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.transci.2016.12.014_bib0100","unstructured":"World Health Organization. http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0011\/268787\/Use-of-Convalescent-Whole-Blood-or-Plasma-Collected-from-Patients-Recovered-from-Ebola-Virus-Disease-for-Transfusion,-as-an-Empirical-Treatment-during-Outbreaks-Eng.pdf; accessed August 24, 2016"},{"key":"10.1016\/j.transci.2016.12.014_bib0105","unstructured":"World Health Organization. http:\/\/apps.who.int\/iris\/bitstream\/10665\/161912\/1\/WHO_HIS_KER_GHE_15.1_eng.pdf; Accessed August 24, 2016"},{"key":"10.1016\/j.transci.2016.12.014_bib0110","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/cid\/civ680","article-title":"The use of ebola convalescent plasma to treat ebola virus disease in resource-constrained settings: a perspective from the field","volume":"62","author":"van Griensven","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0115","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1511812","article-title":"Ebola-Tx consortium evaluation of convalescent plasma for ebola virus disease in Guinea","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1740774515621056","article-title":"Ebola_Tx consortium: design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014\u20132015 outbreak","volume":"13","author":"Edwards","year":"2016","journal-title":"Clin Trials"},{"key":"10.1016\/j.transci.2016.12.014_bib0125","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cid\/civ395","article-title":"Administration of brincidofovir and convalescent plasma in a patient with ebola virus disease","volume":"61","author":"Florescu","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0130","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"Nebraska biocontainment unit and the emory serious communicable diseases unit. The use of TKM-100802 and convalescent plasma in 2 patients with ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.socscimed.2015.11.017","article-title":"GET Members. Taking the bull by the horns: ethical considerations in the design and implementation of an Ebola virus therapy trial","volume":"148","author":"Kombe","year":"2016","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0140","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOH.0000000000000191","article-title":"The use of convalescent plasma to treat emerging infectious diseases: focus on Ebola virus disease","volume":"22","author":"Winkler","year":"2015","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.transci.2016.12.014_bib0145","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1093\/infdis\/jiv042","article-title":"Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia","volume":"211","author":"Gutfraind","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0150","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa1511812","article-title":"Ebola-Tx consortium convalescent plasma for ebola virus disease (letter to the editor)","volume":"374","author":"van Griensven","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0155","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1056\/NEJMoa1504874","article-title":"Working group of the U.S: \u2212European clinical network on clinical management of ebola virus disease patients in the U.S. and Europe. Clinical management of ebola virus disease in the United States and Europe","volume":"374","author":"Uyeki","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0160","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cell.2015.12.022","article-title":"Cross-reactive and potent neutralizing antibody responses in human survivors of natural ebolavirus infection","volume":"164","author":"Flyak","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.transci.2016.12.014_bib0165","article-title":"Efficacy of vesicular stomatitis virus-ebola virus postexposure treatment in rhesus macaques infected with ebola virus makona","volume":"5","author":"Marzi","year":"2016","journal-title":"J Infect Dis"},{"issue":"August","key":"10.1016\/j.transci.2016.12.014_bib0170","article-title":"An adenovirus vaccine expressing ebola virus variant makona glycoprotein is efficacious in Guinea pigs and nonhuman primates","volume":"4","author":"Wu","year":"2016","journal-title":"J Infect Dis"},{"issue":"June 15 (12)","key":"10.1016\/j.transci.2016.12.014_bib0175","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1093\/cid\/ciw202","article-title":"Ebola virus persistence in semen of male survivors","volume":"62","author":"Uyeki","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"October","key":"10.1016\/j.transci.2016.12.014_bib0180","first-page":"14","article-title":"Ebola RNA persistence in semen of ebola virus disease survivors \u2013 preliminary report","author":"Deen","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2016.12.014_bib0185","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/vox.12376","article-title":"Pathogen-reduced Ebola virus convalescent plasma: first steps towards standardization of manufacturing and quality control including assessment of Ebola-specific neutralizing antibodies","volume":"110","author":"Geisen","year":"2016","journal-title":"Vox Sang"},{"issue":"Suppl 1","key":"10.1016\/j.transci.2016.12.014_bib0190","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1111\/trf.13393","article-title":"Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro","volume":"56","author":"Cap","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.transci.2016.12.014_bib0195","doi-asserted-by":"crossref","first-page":"e0003833","DOI":"10.1371\/journal.pntd.0003833","article-title":"Risk factors associated with ebola and marburg viruses seroprevalence in blood donors in the republic of Congo","volume":"9","author":"Moyen","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.transci.2016.12.014_bib0200","doi-asserted-by":"crossref","first-page":"e824","DOI":"10.1186\/s12889-015-2167-6","article-title":"An evaluation of psychological distress and social support of survivors and contacts of Ebola virus disease infection and their relatives in Lagos, Nigeria: a cross sectional study\u20132014","volume":"15","author":"Mohammed","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.transci.2016.12.014_bib0205","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.3389\/fpubh.2016.00163","article-title":"Epidemiological data management during an outbreak of ebola virus disease: key issues and observations from Sierra Leone","volume":"4","author":"Owada","year":"2016","journal-title":"Front Public Health"},{"key":"10.1016\/j.transci.2016.12.014_bib0210","doi-asserted-by":"crossref","first-page":"e130","DOI":"10.3389\/fpubh.2016.00130","article-title":"Contact tracing during an outbreak of ebola virus disease in the western area districts of Sierra Leone: lessons for future ebola outbreak response","volume":"4","author":"Olu","year":"2016","journal-title":"Front Public Health"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216302002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050216302002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T11:54:52Z","timestamp":1536148492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050216302002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1473050216302002"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2016.12.014","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of convalescent plasma in Ebola virus infection","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2016.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}